n.a. (ZMH)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Shares Outstanding 170.40M
Div & Yield N.A. (N.A)
'Real Money' Radio Recap: Time to Play Defense

'Real Money' Radio Recap: Time to Play Defense

Cramer advises listeners to avoid speculative names.

Play Defense to Score Gains

The Procters and Altrias are the L.T. and Ray Lewis of the stock market: They know how to score for you.

Some Take the Knife to Zimmer Surgery

The joint implant firm's heavily touted minimally invasive surgery technique draws critics.

Cramer's 'Mad Money' Recap: A Baby Boomer Portfolio

Cramer's 'Mad Money' Recap: A Baby Boomer Portfolio

Cramer recommends stocks in laser surgery, assisted living, insurance and other sectors.

Zimmer Posts Strong Quarter

But the company's shares slip as Zimmer trims second-half sales forecasts.

WellPoint Looking Fit

But HCA continues to be hit by uninsured patient costs. Plus, gains at Exactech.

Zimmer Hopes Are Hinged on Stellar Growth

But expectations are already sky-high for the big maker of orthopedic implants.

Zimmer, Peers Brace for Pricing Storm

Zimmer, Peers Brace for Pricing Storm

Cost-cutting efforts in the cash-strapped hospital sector could pinch orthopedic implant profits.

Cramer's 'Mad Money' Recap: A Baby Boomer Portfolio

Cramer's 'Mad Money' Recap: A Baby Boomer Portfolio

Cramer recommends stocks in laser surgery, assisted living, insurance and other sectors.

Spine Troubles Slow Biomet

Spine Troubles Slow Biomet

Not able to meet fourth-quarter expectations, the company boosts its dividend and buys back stock.

No Stopping Real Estate Bubble Talk

The chatter is tiresome, but that doesn't mean prices are too high. Also, charts of Beazer and more.

Hospitals Turn Tables on Implants

Companies like Zimmer, Biomet and Stryker could see margins narrow as orthopedic prices come under pressure.

Celebrate Weakness

This atmosphere produces the largest percentage of stocks with growth in earnings.

Stocks It's Not Too Late to Buy, Pt. 2

Stocks It's Not Too Late to Buy, Pt. 2

Jim Cramer presents the second half of his top 10 picks of what can be bought after a three-day rally.

Biomet Gains Hinge on Old Standby

Biomet Gains Hinge on Old Standby

Critics say improvements in the implant maker's newer hip and knee joints are mostly for show.

Oil Services Start to See Action Again

That's the takeaway from the Schlumberger call, where it became clear that it's still too early to sell the drillers.

Zimmer Shows Flexibility

The joint implant maker posts stronger-than-expected numbers.

Probes Could Strike at Stryker

Probes Could Strike at Stryker

Orthopedic device makers such as Zimmer and Smith & Nephew could be vulnerable, some say.

Orthopedics Probe's Deep Roots

Orthopedics Probe's Deep Roots

Hospitals claim the feds have let implant makers such as DePuy, Biomet and Zimmer ratchet up prices. Now change is in the air.

Justice Probe Hammers Stryker, Biomet

Justice Probe Hammers Stryker, Biomet

The government wants to take a look at some lucrative consulting arrangements.

Does Vacation Mean a Trading Hiatus?

The Chartman's taking his computer and charts on vacation, but should you? Also charts on Fannie Mae, Yahoo! and more.

Prognosis Negative for Health Care

A Bush win should give these stocks a shot in the arm, but the longer view isn't optimistic.

If You're Gonna Trade, Have a Backup

A big nest egg or alternative income sources is key to success. Plus, charts of PeopleSoft, Kinross Gold and more.

Profit Grows at Zimmer

Profit Grows at Zimmer

The company beats estimates and offers an upbeat outlook.

Newmont Calls Beckon Ahead of Election

The company is making money hand-over-fist and offers some relief from presidential-race worries.

Dodging Volatility

A big change to a position helps Cramer escape some of the ebb and flow as earnings wear on.

Jim Cramer's Action Alerts PLUS Weekly Roundup

With earnings season on the horizon, it's time to get a game plan in place.

Jim Cramer's Action Alerts PLUS Weekly Roundup

Cramer decides what to do about the late-week rotation into tech and looks at his exposure for the coming week.

Jim Cramer's Action Alerts PLUS Weekly Roundup

At the end of a weak week, Cramer looks at his portfolio and what might work next.

Shaping Up the Portfolio

Yesterday's trade makes for a trade today necessary. Find out how Cramer is striking a balance.